WASHINGTON (Dow Jones)–The U.S. Supreme Court refused Monday to consider a Johnson & Johnson (JNJ) subsidiary’s challenge to a lawsuit alleging that it defrauded Medicare by offering kickbacks to health-care providers for prescribing the anemia drug Procrit.
At issue was a lawsuit …
http://online.wsj.com/article/BT-CO-20100621-706838.html?mod=WSJ_latestheadlines
